Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects communication, social interaction, sensory processing, and behaviour. It can present in many different ways, and the level of support individuals require varies greatly. Some people with ASD may need intensive support throughout life, while others may be highly independent. It is also common for people with ASD to experience additional conditions such as epilepsy, learning difficulties, sleep disorders, and attention challenges.¹
Cerebral folate deficiency (CFD) is a neurological condition where the amount of 5-methyltetrahydrofolate (5-MTHF), the active form of folate needed by the brain, is unusually low in the fluid that surrounds the brain and spinal cord, even when folate levels in the blood are normal². Because folate is crucial for brain development, communication between nerve cells, and maintaining healthy nerve function, this deficiency can lead to developmental, behavioural, and movement-related symptoms.
Some children with CFD show features similar to ASD, such as reduced social communication, speech delays, and repetitive behaviours.² This can make diagnosis challenging because it may appear at first that a child simply has autism. However, CFD is treatable, and in many cases, children improve significantly when it is identified early and managed correctly.² Therefore, understanding the overlap between ASD and CFD is essential so that children receive timely and appropriate treatment.
This article explains ASD and CFD clearly, compares their shared features, and describes when testing for CFD should be considered, especially when ASD-like symptoms are present.
Autism spectrum disorder overview
ASD includes a range of conditions that share core differences in communication and behaviour. These differences usually become noticeable during early childhood, often before the age of three.³ Families may notice differences such as limited eye contact, delayed speech, repetitive movements, or difficulties interacting socially.
Common features of ASD include:
• Difficulties in back-and-forth social interaction, such as conversation or sharing play³
• Challenges interpreting non-verbal communication, including facial expressions or body language³
• Repetitive movements or behaviours, such as rocking or hand-flapping⁴
• A strong preference for routine, and distress when routines change⁴
• Highly focused interests, sometimes very specific or intense¹
• Differences in sensory processing, such as sensitivity to noise or textures⁴
ASD is fairly common. About 1 in every 100 children in the UK is estimated to be autistic.¹
Causes of ASD
ASD does not have a single known cause. Instead, several contributing factors influence development:
• Genetic influences are strong. Many genes associated with brain development may contribute¹
• Environmental influences before or around birth, such as certain infections or premature birth, may play a role³
• Differences in brain processing and communication pathways have been found in imaging studies³
It is important to emphasise that ASD is not caused by parenting styles or vaccines.¹
Associated challenges
Children with ASD may also experience:
• Epilepsy
• Motor coordination difficulties
• ADHD
• Sleep disturbance
• Intellectual disability¹
These co-occurring conditions can affect learning, communication, and daily function.
Cerebral folate deficiency overview
Cerebral folate deficiency is diagnosed when the brain has low levels of 5-MTHF, even though blood folate levels are normal.² 5-MTHF plays a central role in chemical signalling, brain cell growth, and maintaining healthy nerve insulation.
When the brain lacks sufficient folate:
• Brain development may slow
• Communication between nerve cells may be disrupted
• The protective coating around nerves may weaken²
This can lead to changes in movement, behaviour, cognition, and sensory processing.
Causes of CFD
The main causes include:
- Folate receptor alpha autoantibodies (FRα-Ab)
These antibodies interfere with the transport of folate into the brain, preventing it from reaching healthy levels² - Genetic conditions affecting folate processing or transport pathways (such as changes in FOLR1, PCFT, or MTHFR)⁵
- Secondary factors, such as mitochondrial disorders or long-term use of medications that interfere with folate metabolism⁵
How CFD presents
Symptoms vary, but may include:
• Developmental regression (loss of previously acquired skills)²
• Delayed speech development or loss of language⁵
• Seizures, which may be difficult to treat⁶
• Low muscle tone (hypotonia) or stiffness (spasticity)²
• Movement difficulties, including problems with balance or coordination⁵
• Autistic-like behaviours, such as reduced social interest or repetitive actions⁶
• Sleep problems, feeding difficulties, and in some cases, progressive neurological decline²
Overlapping features of ASD and CFD
Because CFD can affect communication, sensory processing, and behaviour, it may look very similar to ASD. Shared features include:
• Reduced social eye contact¹,²
• Delayed or limited speech²
• Repetitive movements or routines³,⁶
• Sensory overload or sensory-seeking behaviours³,⁶
• Irritability, sleep difficulties, or attention challenges⁶
• In some cases, seizures and movement problems¹,²
However, one key difference is that children with CFD often show regression, meaning they lose skills they had previously developed. Regression is less common in ASD.²
This distinction is often what guides clinicians to consider CFD testing.
Diagnostic considerations
ASD is diagnosed through behavioural assessment rather than blood tests. Clinicians use standardised tools and criteria, such as those in DSM-5.¹,³
CFD requires laboratory investigation, especially:
• Cerebrospinal fluid testing to measure 5-MTHF, usually via lumbar puncture²
• Blood tests for folate and vitamin B12
• Testing for folate receptor alpha autoantibodies²
CFD should be considered when:
• A child experiences developmental regression
• Seizures or coordination problems are present
• Speech development is significantly delayed
• Feeding or sleep issues are severe
• There is little progress despite typical autism therapies⁷
Failing to consider CFD may delay effective treatment opportunities.
Treatment of cerebral folate deficiency
The main treatment is folinic acid (leucovorin) supplementation. This form of folate can bypass blocked pathways and restore folate levels in the brain.²
Research has shown that some children treated with folinic acid experience improvements in:
• Communication and language
• Social engagement
• Behavioural self-regulation
• Cognitive skills⁷
Treatment is most effective when started early, during periods of rapid brain development.⁷,⁸
If CFD is caused by folate receptor autoantibodies, avoiding cow’s milk products may also help reduce antibody levels and improve treatment response.⁸
Monitoring usually involves follow-up assessments to track developmental, neurological, and behavioural changes².
FAQs
Is cerebral folate deficiency the same as autism?
No. They are separate conditions, though CFD can sometimes cause behaviours that resemble autism.
Can children improve if CFD is treated?
Yes. Many children show improvements in language, interaction, and behaviour when treatment begins early.
What is the treatment for CFD?
Folinic acid (leucovorin) is the main treatment and helps restore folate levels in the brain.
Does every child with autism need testing for CFD?
No. Testing is usually recommended when ASD-like behaviours occur along with regression, seizures, or motor difficulties.
Do children need a lumbar puncture to diagnose CFD?
Often yes, because it is the only way to accurately measure folate in the brain.
Why might cow’s milk be avoided in CFD?
In some cases, cow’s milk proteins trigger the antibodies that block folate receptors, and avoiding it may improve treatment response.
Summary
ASD and CFD can appear similar because both can affect language development, social communication, behaviour, and sensory responses. However, CFD is distinct because it is caused by a biochemical issue in folate transport or processing and is often treatable.
CFD should be considered when:
• A child loses previously gained skills
• There are seizures or notable movement difficulties
• Response to ASD-targeted therapies is limited
• Parents or clinicians sense that something “does not fit” the ASD-only picture
Early recognition and treatment may significantly improve development and quality of life.
References
- Hodis B, Mughal S, Saadabadi A. Autism Spectrum Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525976/
- Ramaekers VTh, Quadros EV. Cerebral folate deficiency syndrome: Early diagnosis, intervention and treatment strategies. Nutrients. 2022;14(15):3096. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370123/
- Hodges H, Fealko C, Soares N. Autism spectrum disorder: Definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl 1):S55–65. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082249/
- Qin L, Wang H, Ning W, Cui M, Wang Q. New advances in the diagnosis and treatment of autism spectrum disorders. Eur J Med Res. 2024;29(1):322. Available from: https://doi.org/10.1186/s40001-024-01916-2
- Pope S, Artuch R, Heales S, Rahman S. Cerebral folate deficiency: Analytical tests and differential diagnosis. J Inherit Metab Dis. 2019;42(4):655–72. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jimd.12092
- Serrano M, Pérez-Dueñas B, Montoya J, Ormazabal A, Artuch R. Genetic causes of cerebral folate deficiency: Clinical, biochemical and therapeutic aspects. Drug Discov Today. 2012;17(23–24):1299–306. Available from: https://www.sciencedirect.com/science/article/pii/S1359644612002620
- Rossignol DA, Frye RE. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin treatment in autism spectrum disorders: A systematic review and meta-analysis. J Pers Med. 2021;11(11):1141. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622150/
- Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013;18(3):369–81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578948/

